|
trastuzumab 150 mg (INJECTION)
|
$6.0259
|
|
VA Big4
|
|
| Ontruzant (150) |
Merck Sharp & Dohme Corporation |
|
|
trastuzumab 150 mg (INJECTION)
|
$6.2128
|
|
VA FSS
|
|
| Ontruzant (150) |
Merck Sharp & Dohme Corporation |
|
|
trastuzumab 150 mg (INJECTION)
|
$364.5848
|
|
AUS PBS
|
generic
|
| Ontruzant (1) |
Organon Pharma Pty Ltd |
| Ogivri (1) |
Alphapharm Pty Ltd |
| Herzuma (1) |
Celltrion Healthcare Australia Pty Ltd |
| Kanjinti (1) |
Amgen Australia Pty Limited |
| Trazimera (1) |
Pfizer Australia Pty Ltd |
| Herceptin (1) |
Roche Products Pty Ltd |
|
|
trastuzumab 150 mg (INJECTION)
|
$399.3900
|
|
VA NC
|
|
| Ontruzant (1) |
Merck & Co., Inc |
|
|
trastuzumab 150 mg / 20 mL (20 mL INJECTION)
|
$934.8400
|
|
VA Big4
|
|
| HERZUMA (1) |
Teva Pharmaceuticals USA, Inc. |
|
|
trastuzumab 150 mg / 20 mL (20 mL INJECTION)
|
$1127.6400
|
|
VA FSS
|
|
| HERZUMA (1) |
Teva Pharmaceuticals USA, Inc. |
|
|
trastuzumab 150 mg / 7.15 mL (7.2 mL INJECTION)
|
$5376.3710
|
|
VA Big4
|
|
| Kanjinti (0.1) |
Amgen USA, Inc. |
|
|
trastuzumab 150 mg / 7.15 mL (7.2 mL INJECTION)
|
$9487.6925
|
|
VA FSS
|
|
| Kanjinti (0.1) |
Amgen USA, Inc. |
|
|
trastuzumab 150 mg / 7.4 mL (7.4 mL INJECTION)
|
$562.2800
|
|
VA FSS
|
|
| OGIVRI (1) |
Mylan Institutional LLC |
|
|
trastuzumab 150 mg / 7.4 mL (7.4 mL INJECTION)
|
$1070.3900
|
|
VA Big4
|
|
| Herceptin (1) |
Genentech USA |
|
|
trastuzumab 150 mg / 7.4 mL (7.4 mL INJECTION)
|
$1087.1460
|
|
VA Big4
|
|
| Herceptin (10) |
Genentech USA |
|
|
trastuzumab 150 mg / 7.4 mL (7.4 mL INJECTION)
|
$1520.6300
|
|
VA FSS
|
|
| Herceptin (1) |
Genentech USA |
|
|
trastuzumab 150 mg / 7.4 mL (7.4 mL INJECTION)
|
$1558.4200
|
|
VA FSS
|
|
| Herceptin (10) |
Genentech USA |
|
|
trastuzumab 420 mg (INJECTION)
|
$1020.8298
|
|
AUS PBS
|
generic
|
| Kanjinti (1) |
Amgen Australia Pty Limited |
|
|
trastuzumab 420 mg / 20 mL (20 mL INJECTION)
|
$40563.6000
|
|
VA Big4
|
|
| Kanjinti (0.1) |
Amgen USA, Inc. |
|
|
trastuzumab 420 mg / 20 mL (20 mL INJECTION)
|
$74309.4000
|
|
VA FSS
|
|
| Kanjinti (0.1) |
Amgen USA, Inc. |
|
|
trastuzumab 600 mg / 5 mL (INJECTION)
|
$1181.8363
|
|
AUS PBS
|
generic
|
| Herceptin SC (1) |
Roche Products Pty Ltd |
|
|
trastuzumab 60 mg (INJECTION)
|
$145.8339
|
|
AUS PBS
|
generic
|
| Trazimera (1) |
Pfizer Australia Pty Ltd |
| Herceptin (1) |
Roche Products Pty Ltd |
|
